Combihale FB 0.5 mg Respules 5x2 ml is used to treat asthma and chronic obstructive pulmonary diseases (COPD). It helps prevent and treat difficulty breathing, wheezing, shortness of breath, coughing, and chest tightness associated with asthma and COPD.

Combihale FB 0.5 mg Respules 5x2 ml contains Budesonide and Formoterol. Budesonide reduces the swelling of the airways, and Formoterol works by relaxing and opening air passages in the lungs, making it easier to breathe.

Some people may experience fungal infection in the mouth, headache, sore throat, hoarse voice, upper respiratory tract infection, flu, cough, back pain, increased heart rate, and trembling. If the side effects persist or worsen, please consult your doctor.

Do not take Combihale FB 0.5 mg Respules 5x2 ml if you are allergic to any of its components. If you are pregnant or breastfeeding, consult your doctor before using Combihale FB 0.5 mg Respules 5x2 ml. Keep your doctor informed about your medications and medical conditions to prevent any potential interactions.

Combihale FB 0.5 mg Respules 5x2 ml is used in the treatment of Asthma and Chronic Obstructive Pulmonary Disease (COPD). The detailed uses of Combihale FB 0.5 mg Respules 5x2 ml are as follows:

• Asthma management: Combihale FB 0.5 mg Respules 5x2 ml is widely prescribed for asthma patients to reduce inflammation and prevent asthma attacks. It works by relaxing airway muscles, easing breathing and providing effective relief.
• COPD treatment: Combihale FB 0.5 mg Respules 5x2 ml is highly effective in managing chronic obstructive pulmonary disease (COPD), a progressive lung condition. It helps alleviate symptoms like breathlessness and wheezing, ensuring better respiratory function.
• Maintenance therapy: It is used as regular maintenance therapy and as needed in response to symptoms.

• Follow your doctor's instructions on the dosage and timing of this medication to ensure safe and effective use.
• Hold Combihale FB 0.5 mg Respules 5x2 ml with the mouthpiece downwards. Put the mouthpiece between your teeth and seal the lips around it. Then, press down on the inhaler once to release the medication. Breathe in slowly and hold your breath for 5 to 10 seconds. Breathe out slowly. Repeat the process until you have inhaled the number of puffs prescribed by the doctor.
• Rinse your mouth with water and spit it out after using Combihale FB 0.5 mg Respules 5x2 ml to avoid fungal infections in the mouth and throat.

• Combihale FB 0.5 mg Respules 5x2 ml is a combination inhalation therapy that contains Budesonide (an inhaled corticosteroid) and Formoterol (a long-acting beta-2 adrenergic agonist).
• This combination offers both anti-inflammatory and bronchodilator actions, providing comprehensive control over respiratory conditions such as Asthma and Chronic Obstructive Pulmonary Disease (COPD).
• Budesonide reduces airway inflammation, while Formoterol helps to relax the airway muscles, leading to improved airflow and reduced breathlessness.
• Combihale FB 0.5 mg Respules 5x2 ml is used as a regular maintenance therapy for individuals with asthma where the use of inhaled corticosteroids and long-acting beta-agonists (LABA) is appropriate.
• It reduces airway inflammation and prevents bronchospasm, thereby minimising the frequency and severity of asthma attacks.
• Helps maintain long-term asthma control, improves lung function, and enhances quality of life.
• Combihale FB 0.5 mg Respules 5x2 ml is also indicated for the regular treatment of moderate to severe COPD in patients who experience frequent symptoms and have a history of exacerbation.
• Combihale FB 0.5 mg Respules 5x2 ml decreases the rate and severity of COPD exacerbations and maintains day-to-day function.

• Do not use Combihale FB 0.5 mg Respules 5x2 ml if you are allergic to any of its components.
• If you are pregnant or breastfeeding, it is advised to inform your doctor before using Combihale FB 0.5 mg Respules 5x2 ml.
• Combihale FB 0.5 mg Respules 5x2 ml is not recommended for children below 6 years of age.
• If your breathing worsens or you often wake up at night with asthma, experience chest tightness in the morning that lasts longer than usual, please consult a doctor immediately, as these might be signs indicating that your asthma is not controlled properly and requires an alternate or additional treatment.
• Regular monitoring of potassium levels is recommended while taking Combihale FB 0.5 mg Respules 5x2 ml, as it may cause low potassium levels in the blood.
• Avoid contact with people who have infections or who are sick, as Combihale FB 0.5 mg Respules 5x2 ml may weaken the immune system, causing infections to be easily contracted.
• If you have high blood pressure, diabetes, hypokalaemia (low potassium levels in the blood), glaucoma, cataracts, osteoporosis (weak bones), fits, immune system problems, chickenpox, measles, thyroid, lung, heart, liver or adrenal gland problems, inform your doctor before using Combihale FB 0.5 mg Respules 5x2 ml.